dhr. prof. dr. C.J.J. (Carel) Richter
-
Universiteitsbibliotheek
Sector Bijzondere Collecties
-
Plantage Middenlaan
45-45A
1018 DC Amsterdam
-
C.J.J.Richter@uva.nl
2014
- N. Langebeek, H.G. Sprenger, E.H. Gisolf, P. Reiss, M.A.G. Sprangers, J. Legrand, C.J.J. Richter & P.T. Nieuwkerk (2014). A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV MEDICINE, 15 (5), 286-290. doi: 10.1111/hiv.12112
- N. Langebeek, E.H. Gisolf, P. Reiss, S.C. Vervoort, T.B. Hafsteinsdóttir, C.J.J. Richter, M.A.G. Sprangers & P.T. Nieuwkerk (2014). Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Medicine, 12 (1), 142. doi: 10.1186/s12916-014-0142-1
2012
- R. Zoutendijk, H.L. Zaaijer, T.E.M.S. de Vries-Sluijs, J.G.P. Reijnders, J.W. Mulder, F.P. Kroon, C.J.J. Richter, A.A. van der Eijk, M.J. Sonneveld, B.E. Hansen, R.A. de Man, M.E. van der Ende & H.L.A. Janssen (2012). Hepatitis B surface antigen declines and clearance during long-term tenofovir therapy in patients coinfected with HBV and HIV. The Journal of Infectious Diseases, 206 (6), 974-980.
- S. Zhang, A. van Sighem, A. Kesselring, L. Gras, C. Smit, J.M. Prins, R. Kauffmann, C.J.J. Richter, F. de Wolf & P. Reiss (2012). Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 60 (3), 265-272.
- N. Langebeek, H. Sprengers, E. Gisolf, C.J.J. Richter, M. Sprangers, P. Reiss & P. Nieuwkerk (2012). Does a simplified regimen give a better adherence, treatment satisfaction, and quality of life? Journal of the International AIDS Society, 15 (6), 18091.
2011
- J.E. Arends, F.A.E. Lambers, J.T.M. van der Meer, G. Schreij, C.J.J. Richter, K. Brinkman & A.I.M. Hoepelman (2011). Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management. The Netherlands Journal of Medicine, 69 (1), 43-49.
- M. van Luin, F.W. Wit, C. Smit, I.M. Rigter, E.J.F. Franssen, C.J.J. Richter, F. Kroon, F. de Wolf & D.M. Burger (2011). Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands. Therapeutic Drug Monitoring, 33 (1), 32-39.
- H.S.M. Ammerlaan, J.A.J.W. Kluytmans, H. Berkhout, A. Buiting, E.I.G.B. de Brauwer, P.J. van den Broek, P. van Gelderen, S.C.A.P. Leenders, A. Ott, C.J.J. Richter, L. Spanjaard, I.J.B. Spijkerman, F.H. van Tiel, G.P. Voorn, M.W.H. Wulf, J. van Zeijl, A. Troelstra & M.J.M. Bonten (2011). Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. Journal of Antimicrobial Chemotherapy, 66 (10), 2418-2424. doi: 10.1093/jac/dkr250
- H.S.M. Ammerlaan, J.A.J.W. Kluytmans, H. Berkhout, A. Buiting, E.I.G.B. de Brauwer, P.J. van den Broek, P. van Gelderen, S.C.A.P. Leenders, A. Ott, C.J.J. Richter, L. Spanjaard, I.J.B. Spijkerman, F.H. van Tiel, G.P. Voorn, M.W.H. Wulf, J. van Zeijl, A. Troelstra & M.J.M. Bonten (2011). Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. Journal of Antimicrobial Chemotherapy, 66 (10), 2409-2417. doi: 10.1093/jac/dkr243
2010
- T.E.M.S. de Vries-Sluijs, J.G.P. Reijnders, B.E. Hansen, H.L. Zaaijer, J.M. Prins, S.D. Pas, M. Schutten, A.I.M. Hoepelman, C. Richter, J.W. Mulder, R.A. de Man, H.L.A. Janssen & M.E. van der Ende (2010). Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus. Gastroenterology, 139 (6), 1934-1941.
- M. van Luin, M.E. van der Ende, C.J.J. Richter, M. Visser, D. Faraj, A. van der Ven, L. Gelinck, F. Kroon, F.W. Wit, R.H. van Schaik, P.F. Kuks & D.M. Burger (2010). Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. AIDS, 24 (8), 1223-1226. doi: http://dx.doi.org/10.1097/QAD.0b013e3283389129
2009
- M. van Luin, L. Gras, C. Richter, M.E. van der Ende, J.M. Prins, F. de Wolf, D.M. Burger & F.W. Wit (2009). Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations. Journal of Acquired Immune Deficiency Syndromes, 52 (2), 240-245.
This page has been automatically generated by the UvA-Current Research Information System. If you have any questions about the content of this page, please contact the UBAcoach or the Metis staff of your faculty / institute. To edit your publications login to Personal Metis.